Skip to main content
 

We are led by a team of seasoned experts in the field of microbiome research dedicated to the treatment and prevention of disease through therapeutics that target the interactions between the human host and the trillions of microbiota that make up the microbiome.

Graham Waters
Chief Executive Officer
Kevin Chapman
Head, Global Regulatory Affairs
Jon Boleat
Head of Finance
Brett Sousa, MBA
Head of Corporate Strategy and Commercial Development